|
Dr. Hale began
his practice in Milwaukee, Wisconsin in 1979. As a general ophthalmologist, he diagnosed and treated all major ocular disorders and provided routine eye care.
In 1984, he became involved in refractive surgery (surgery designed to reduce or eliminate dependence on eyeglasses / contact lenses), and began to commit his time and efforts toward the development and refinement of new techniques and instrumentation.
In
1991, he became involved in FDA studies in RK and
later on he participated in FDA studies of the excimer
laser- an advanced version of which we now use for
LASIK. He also co-directed physician
training courses, helping hundreds of surgeons enter the field of refractive surgery.
In 1994, he
actively participated in the Chiron Keratorefractive
Study Group "Prospective Evaluation of Radial
Keratotomy"
and became a member of the International Scientific
Advisory Board for Chiron Vision. In 1995, he became part of the Chiron Technolas Excimer Laser
FDA Investigational Studies for the correction of
myopia and astigmatism.
In
1996, Dr. Hale was asked to commute monthly to Arizona
to co-direct a university based keratorefractive and
corneal fellowship program. This led to the formation
of clinical practices dedicated to refractive surgery
in both Wisconsin and Arizona. In 1998, he made the
professional decision to fully dedicate his career
and practices to vision correction surgery.
Dr.
Hale has been presented with the "VISX Star"
award
all three years that it has been awarded. This honor
is given to the top laser surgeons in the United States,
acknowledging their significant contributions to the
enhancement, growth and improvement of the field
of refractive surgery.
In
2000, as a result of his relentless pursuit of excellence
and dedication to the specialty of vision correction
surgery, he founded the Advanced Vision Correction
Foundation. The goal of this foundation is to be a
leader in research, development, and training of new
and innovative techniques, as well as to
provide support
to other surgeons.
|